Review of the clinical experience with a modified release form of tacrolimus [FK506E (MR4)] in transplantation

Clinical Transplantation

Volumn 20, Issue SUPPL. 17, 2006, Pages 80-84

  Wente, Moritz N ^a   Sauer, Peter ^a   Mehrabi, Arianeb ^a   Weitz, Jürgen ^a   Büchler, Markus W ^a   Schmidt, Jan ^a   Schemmer, Peter ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Compliance; Immunosuppression; Kidney transplantation; Liver transplantation; Tacrolimus

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CYCLOSPORIN; TSUKUBAENOLIDE;

ACUTE GRAFT REJECTION; AREA UNDER THE CURVE; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; DRUG SAFETY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; STANDARDIZATION; SURVIVAL RATE;

DELAYED-ACTION PREPARATIONS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; TACROLIMUS;

EID: 33750730612     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2006.00605.x     Document Type: Review

References (25)

1. Busuttil RW, Lake JR. Role of tacrolimus in the evolution of liver transplantation. Transplantation 2004: 77: S44.
2. Undre NA, Stevenson P, Schafer A. Pharmacokinetics of tacrolimus: clinically relevant aspects. Transplant Proc 1999: 31: 21S.
3. European FK506 Multicenter Liver Study Group. Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. Lancet 1994: 344: 423.
4. Klintmalm GB, Goldstein R, Gonwa TH, US Multicenter FK506 Liver Study Group. Use of prograf (FK506) as rescue therapy for refractory rejection after liver transplantation. Transplant Proc 1993: 25: 679.
5. US Multicenter FK506 Liver Study Group. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med 1994: 331: 1110.
6. First MR, Fitzsimmons W. Modified release tacrolimus. Yonsei Med J 2004: 45: 1127.
7. Didlake RH, Dreyfus K, Kerman RH, Van Buren CT, Kahan BD. Patient noncompliance: A major cause of late graft failure in cyclosporine-treated renal transplants. Transplant Proc 1998: 20: 63.
8. Hilbrands LB, Hoitsman AJ, Koene RA. Medication compliance after renal transplantation. Transplantation 1995: 60: 914.
9. Sketris I, Waite N, Grobler K, West M, Gerus S. Factors affecting compliance with cyclosporine in adult renal transplant patients. Transplant Proc 1994: 26: 2538.
10. Bunzel B, Laederach-H ofmann K. Solid organ transplantation - are there predictors for posttransplant noncompliance? A literature overview. Transplantation 2000: 70: 711.
11. Butler JA, Roderick P, Mullee M, Mason JC, Peveler RC. Frequency and impact of nonadherence to immunosuppressants after transplantation: A systematic review. Transplantation 2005: 77: 769.
12. Regazzi MB, Alessiani M, Rinaldi M. New strategies in immunosuppression. Transplant Proc 2005: 37: 2675.
13. First MR, Fitzsimmons W. New drugs to improve transplant outcomes. Transplantation 2004: 77: S88.
14. Schweizer RT, Rovelli M, Palmeri D, Vossler E, Hull D, Bartus S. Noncompliance in organ transplant recipients. Transplantation 1990: 49: 374.
15. Steinberg S, Tacrolimus Modified Release Stable Kidney Conversion Study Group. A one year follow-up study of stable kidney transplant recipients converted from twice daily prograf to once daily modified release tacrolimus. Am J Transplant 2005: 5: 193. (abstract).
16. Alloway R, Tacrolimus Modified Release Kidney Conversion Study Group. Conversion of stable kidney transplant recipients from a twice daily prograf based regimen to a once daily modified release tacrolimus based regimen. Transplantation 2004: 78: 142. (abstract).
17. Alloway R, Tacrolimus Modified Release Kidney Conversion Study Group. Conversion of stable kidney transplant recipients from a twice daily prograf based regimen to a once daily modified release tacrolimus based regimen. Am J Transplant 2004: 4: 230 (abstract).
18. Alloway R, Steinberg S, Khalil K, Gourishankar S, Miller J, Norman D et al. Conversion of stable kidney transplant recipients from a twice daily prograf based regimen to a once daily modified release tacrolimus based regimen. Transplant Proc 2005: 37: 867.
19. Undre A, Tacrolimus Modified Release Kidney Study Group. Use of a once daily modified release tacrolimus regimen in de novo kidney transplant recipients. Am J Transplant 2005: 5: 190 (abstract).
20. Alloway R, Tacrolimus Modified Release Stable Liver Conversion Study Group. A one year follow-up study of stable liver transplant recipients converted from twice daily prograf to once daily modified release tacrolimus. Am J Transplant 2005: 5: 393 (abstract).
21. Florman S, Tacrolimus Modified Release Liver Conversion Study Group. Conversion of stable liver transplant recipients from a twice daily prograf based regimen to a once daily modified release tacrolimus based regimen. Transplantation 2004: 78: 119 (abstract).
22. Florman S, Tacrolimus Modified Release Liver Conversion Study Group. Conversion of stable liver transplant recipients from a twice daily prograf based regimen to a once daily modified release tacrolimus based regimen. Am J Transplant 2004: 4: 268 (abstract).
23. Florman S, Alloway R, Kalayoglu M, Lake K, Bak T, Klein A et al. Conversion of stable liver transplant recipients from a twice daily prograf based regimen to a once daily modified release tacrolimus based regimen. Transplant Proc 2005: 37: 1211.
24. Heffron TG, Tacrolimus Modified Release Liver Conversion Study Group. Conversion of stable pediatric liver transplant recipients from twice daily prograf to once daily modified release tacrolimus. Am J Transplant 2005: 5: 511 (abstract).
25. U ndre A, Tacrolimus Modified Release Liver Study Group. Use of a once daily modified release tacrolimus regimen in de novo liver transplant recipients. Am J Transplant 2005: 5: 374 (abstract).